Items where SHU Author is "Bunning, Rowena"

Up a level
Export as [feed] RSS
Group by: Item Type | Full Text | No Grouping
Jump to: Article
Number of items: 18.

Article

DUNN, Sara, WILKINSON, J.M., CRAWFORD, A., LE MAITRE, C.L. and BUNNING, Rowena (2013). Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes. Osteoarthritis and Cartilage. (In Press)

WANG, Jianru, TIAN, Ye, PHILLIPS, Kate L. E., CHIVERTON, Neil, HADDOCK, Gail, BUNNING, Rowena, CROSS, Alison, SHAPIRO, Irving M., LE MAITRE, Christine and RISBUD, Makarand V. (2013). Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis & rheumatism, 65 (3), 832-842.

WANG, Jianru, TIAN, Ye, PHILLIPS, Kate L. E., CHIVERTON, Neil, HADDOCK, Gail, BUNNING, Rowena, CROSS, Alison, SHAPIRO, Irving M., LE MAITRE, Christine and RISBUD, Makarand V. (2013). Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis & rheumatism, 65 (3), 832-842.

TURNER, Sharon L., MANGNALL, David, BIRD, Nigel C., BUNNING, Rowena and BLAIR-ZAJDEL, Maria E. (2012). Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines. International Journal of Oncology, 41 (3), 1043-1049.

HURST, Louise A., BUNNING, Rowena, SHARRACK, Basil and WOODROOFE, Nicola (2012). siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line. Neuroscience Letters, 521, 52-56.

DUNN, S.L., WILKINSON, J. M., CRAWFORD, A., LE MAITRE, C. and BUNNING, R. A. D. (2012). Cannabinoids: novel therapies for arthritis? Future Medicinal Chemistry, 4 (6), 713-725.

HURST, Louise A., BUNNING, Rowena A.D., SHARRACK, Basil and WOODROOFE, M. Nicola (2012). siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line. Neuroscience Letters, 521 (1), 52-56.

TURNER, S. L., MANGNALL, D., BIRD, N. C., BLAIR-ZAJDEL, M. E. and BUNNING, R. A. D. (2010). Effects of Pro-Inflammatory Cytokines on the Production of Soluble Fractalkine and ADAM17 by HepG2 Cells. Journal of gastrointestinal and liver diseases, 19 (3), 265-271.

HURST, L. A., BUNNING, R. A. D., COURAUD, P.-O., ROMERO, I. A., WEKSLER, B. B., SHARRACK, B. and WOODROOFE, M. N. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Journal of neuroimmunology, 210 (1-2), 108-112.

REID, M. J., CROSS, A. K., HADDOCK, G., ALLAN, S. M., STOCK, C. J., WOODROOFE, M. N., BUTTLE, D. J. and BUNNING, R. A. D. (2009). ADAMTS-9 expression is up-regulated following transient middle cerebral artery occlusion (tMCAo) in the rat. Neuroscience letters, 452 (3), 252-257.

TURNER, S. L., BLAIR ZAJDEL, M. E. and BUNNING, R. A. D. (2009). ADAMs and ADAMTSs in cancer. British journal of biomedical science, 66 (2), 117-128.

HADDOCK, G., CROSS, A. K., ALLAN, S., SHARRACK, B., CALLAGHAN, J. T., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, M. N. (2007). Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the rat. Biochemical Society Transactions, 35 (4), p. 692.

filefilefile
CROSS, A. K., HADDOCK, G., STOCK, C. J., ALLAN, S., SURR, J., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, N. (2006). ADAMTS -1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain research, 1088 (1), 19-30.

MBVUNDULA, E. C., BUNNING, R. A. D. and RAINSFORD, K. D. (2005). Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1α-induced matrix degradation in bovine articular chondrocytes in-vitro. Journal of pharmacy and pharmacology, 58 (3), 351-358.

HADDOCK, G., CROSS, A. K., PLUMB, J., SURR, J., BUTTLE, D. J., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter. Multiple Sclerosis, 12 (4), 386-396.

PLUMB, J., MCQUAID, S., CROSS, A. K., SURR, J., HADDOCK, G., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Multiple Sclerosis, 12 (4), 375-385.

MBVUNDULA, E. C., BUNNING, R. A. D. and RAINSFORD, K. D. (2004). Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. Biochemical pharmacology, 69 (4), 635-640.

GODDARD, D. R., BUNNING, R. A. D. and WOODROOFE, M. N. (2001). Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia, 34 (4), p. 267.

This list was generated on Thu Oct 23 04:04:58 2014 IST.